Release Therapeutics, a privately held Swiss BioMedTech company based at Campus Biotech in Geneva, announced that it has been awarded…

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to CINAINU® (LH-8), an investigational topical treatment for…

Geneva University Hospitals (HUG) are now Switzerland’s most advances hospital in the digital field. In the 2027 edition of Newsweek…

dEEGtal, S-SENTIA and Juturna Bio are the latest projects to receive funding from the FIF, the Canton of Geneva’s innovation…

Geneva-based eye care leader Alcon has acquired Neurotech Pharmaceuticals, a private biotech company developing therapies for chronic eye diseases, for…

Orbis Medicines Signs Drug Discovery Deal with Novo Nordisk Worth Up to USD 1.4 billion Orbis Medicines, a biotech company…

MazeBio, Akteon and HelixScreen are supported by the EPFL Startup Launchpad and taking the next steps towards bringing their technologies to…

Dr Millicent Dockerill, researcher at the University of Geneva’s Department of Organic Chemistry and founder of the UNIGE spin-off Reverso…

On 15 October 2026, the Geneva University Hospitals (HUG) held the 20th edition of their Innovation Day. The event connects…

Ready to sell? What it really takes to go from innovation to commercialisation.Your product is approved. Now what? On 5…

Gondola Medical Technologies, a medtech company with roots in Ticino and Vaud, has been granted a four-month debt-restructuring moratorium (sursis…

On 14 October, Magali Bischof, Secretary General of Swiss Health Valley by BioAlps, was the guest of La Matinale on…